Dr. Enejosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 North Waukegan Road
Chicago, IL 60611
Education & Training
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1991 - 1994
University of the Philippines College of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 2006 - 2026
FL State Medical License 1996 - 2025
NY State Medical License 2002 - 2025- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- 14 citationsSwitching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis.Roy Fleischmann, Ricardo Blanco, Stephen Hall, Glen T D Thomson, Filip Van den Bosch
Annals of the Rheumatic Diseases. 2021-04-01 - 6 citationsCharacterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe SubstrateMohamed-Eslam F. Mohamed, Mukul Minocha, Sheryl Trueman, Tian Feng, Jeffrey Enejosa
Clinical Pharmacology in Drug Development. 2021-03-01 - 136 citationsSafety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programmeStanley Cohen, Ronald F van Vollenhoven, Kevin L. Winthrop, Cristiano A. F. Zerbini, Yoshiya Tanaka
Annals of the Rheumatic Diseases. 2021-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
